Hepatitis C Quick Start
Download Hepatitis C Quick Start full books in PDF, epub, and Kindle. Read online free Hepatitis C Quick Start ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Kathleen M Davis Np |
| Publisher | : |
| Total Pages | : 99 |
| Release | : 2020-04-26 |
| Genre | : |
| ISBN | : |
Hepatitis C Quick Start: A guide for the clinician is written for clinicians and other health care professionals who need quick access to the fundamentals of chronic Hepatitis C virus (HCV) infection. With the U.S. Preventative Services Task Force (USPSTF) recommendation that all people ages 18 and up be tested for HCV infection, it is anticipated that 800,000 new cases will be diagnosed.What is chronic hepatitis C? What is the current treatment? Is the treatment curative? Can any medical provider treat HCV? The author has taken her years of research and experience treating patients with chronic HCV and put it in this accessible and comprehensive format to provide you with evidence based guidelines, patient testimonies, practical applications, and patient education handouts.After reading Quick Start you will be comfortable and confident with your understanding of hepatitis C and the guidelines for treatment and prevention, and in turn will be able to render evidence based care and direction to your patients.
| Author | : Nicolas Goossens |
| Publisher | : Springer |
| Total Pages | : 91 |
| Release | : 2016-05-25 |
| Genre | : Medical |
| ISBN | : 3319280538 |
This book is a concise and up-to-date review of the clinical features, pathophysiology, diagnosis, and treatment of patients with hepatitis C. Busy health care professionals who want a quick review of hepatitis C and new developments in treatment for hepatitis C will benefit from this succinct guide. Hepatitis C virus primarily infects liver cells and can lead to chronic damage to the liver. Patients with hepatitis C infection often develop liver sequelae such as fibrosis, cirrhosis, and hepatocellular carcinoma if left untreated. It is estimated that 150 million people worldwide are infected with hepatitis C virus, and if eradication is to be achieved it is imperative to diagnose and treat such individuals.
| Author | : World Health Organization |
| Publisher | : World Health Organization |
| Total Pages | : 0 |
| Release | : 2017 |
| Genre | : Medical |
| ISBN | : 9789241549981 |
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviors and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination. These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.
| Author | : Nancy Reau |
| Publisher | : Oxford University Press |
| Total Pages | : 201 |
| Release | : 2018-02-23 |
| Genre | : Medical |
| ISBN | : 0190238291 |
Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care. The New Hepatitis C is a current and essential review of HCV's epidemiology, diagnosis, and clinical approaches -- a clinician's guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed, as are important new treatment options for HCV, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C. Updated to detail the standards of care that will define the next decade of HCV management, this evidence-based volume is an essential clinical reference for to any practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine.
| Author | : |
| Publisher | : |
| Total Pages | : 1 |
| Release | : 2006 |
| Genre | : Hepatitis C |
| ISBN | : |
| Author | : Beth Ann Petro Roybal |
| Publisher | : Simon and Schuster |
| Total Pages | : 186 |
| Release | : 2002-09-05 |
| Genre | : Health & Fitness |
| ISBN | : 156975134X |
A Simon & Schuster eBook. Simon & Schuster has a great book for every reader.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 187 |
| Release | : 2016-06-01 |
| Genre | : Medical |
| ISBN | : 0309438020 |
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.
| Author | : Fred Poordad |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 145 |
| Release | : 2016-01-07 |
| Genre | : Medical |
| ISBN | : 0323413374 |
Clinical information about Hepatitis C is quickly outdated, so Dr. Poordad has assembled expert authors to provide state-of-the-art clinjcal reviews for hepatologists. This issue is uniquely organized to present articles based on therapeutic regimens for certain types of patients: Regimens for the Treatment-Naïve Patient; Regimens for Treatment of the Interferon-Failure Patient; Regimens for DAA Failure Patients; Regimens for the Cirrhotic Patient; Regimens for the Peri-Transplant Patient; Regimens for the HIV-Co-Infected Patient; and Next-generation Regimens: The Future of HCV Therapy. This presentation will be very clinically relevant for the practicing hepatologist.
| Author | : Imran Shahid |
| Publisher | : BoD – Books on Demand |
| Total Pages | : 214 |
| Release | : 2018-10-10 |
| Genre | : Medical |
| ISBN | : 1789842077 |
The propagation of hepatitis C from acute to chronic infection and afterward to end-stage liver diseases (hepatic fibrosis, cirrhosis, and hepatocellular carcinoma) involves a highly orchestrated series of molecular and cellular events, including a plethora of genes and cell signaling cascades. The treatment paradigms was revolutionized after the development and approval of all oral interferon-free direct-acting antivirals achieving higher sustained virologic response rates in treated individuals. This book pragmatically overviews the intricate interplay between viral and host factors during hepatitis C virus infection progression, as well as other hepatitis C-associated clinical implications. Hepatitis C - From Infection to Cure also provides up-to-date information about hepatitis C cures for clinicians, physicians, and healthcare providers with an ample understanding of the current treatment horizon, as well as other investigational and emerging treatment strategies. The authors with their valuable scientific contributions belong to many eminent institutes around the world and are much experienced in hepatitis C virology, pathology, and therapeutics.
| Author | : Martina Smolic |
| Publisher | : BoD – Books on Demand |
| Total Pages | : 240 |
| Release | : 2017-10-04 |
| Genre | : Medical |
| ISBN | : 9535135635 |
In the past few years, remarkable progress has been made in our understanding of HCV biology, pathogenesis of infection, and structure-function relationships. This has led to quantum advances in clinical efficacy and tolerability. Yet, in spite of this amazing progress, there remain obstacles to widespread successful treatment. These issues include biological failures even with direct-acting agents, lack of options for individual with organ failures, drug-drug interactions, access to medications either due to lack of availability or affordability, and psychiatric and social issues. These problems are likely to remain in the future. Therefore, this book has been created by distinguished faculties from around the world to address the progress in our understanding of HCV infection and to review new treatment options, limitations, and accessibility of new therapeutic options.
